Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified bifunctional anti-human signal regulatory protein alpha (SIRPa) antibody and method of use thereof for treating cancer

Modified bifunctional anti-human signal regulatory protein alpha (SIRPa) antibody and method of use thereof for treating cancer

US Patent 11713356 · Granted Aug 1, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Humanized anti-CLEC-1A antibodies and antigen-binding fragments thereof2025
Humanized anti-CLEC-1A antibodies and antigen-binding fragments thereof2025
Antibodies directed against CD1272025
Antibodies directed against CD1272025
Antibodies directed against CD1272025
Uses of anti-SIRPg antibodies2025
Uses of anti-SIRPg antibodies2025
Uses of anti-SIRPg antibodies2025
Humanized anti-human-PD-1 antibody and methods of using them for cancer treatmen2025
Humanized anti-human-PD-1 antibody and methods of using them for cancer treatmen2025
Method effector cells using anti-CD127 antibodies for applications in cell thera2025
Method effector cells using anti-CD127 antibodies for applications in cell thera2025